Consumer staples ETFs often serve as defensive holdings during uncertain economic times, yet not every fund in this space follows the same blueprint. The iShares U.S. Consumer Staples ETF (IYK) and the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) both focus on essential-goods companies, but they differ in how they construct their portfolios. IYK relies on market-capitalization weighting that favors the largest players, while RSPS applies equal weighting across S&P 500 staples names. Understanding these differences helps when evaluating concentration risk, costs, diversification, and overall positioning in the defensive sector.
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index and holds about 54 to 58 securities with a net expense ratio near 0.38%. Sponsored by BlackRock's iShares, the fund has been around since 2000. Even with the index caps, it stays fairly concentrated, with top holdings such as PG (Procter & Gamble), KO (Coca-Cola), PM (Philip Morris International), PEP (PepsiCo), CVS (CVS Health), MO (Altria Group), MCK (McKesson), MDLZ (Mondelez International), CL (Colgate-Palmolive), and MNST (Monster Beverage) making up roughly 66% of assets. Consumer staples represent about 83–85% of the fund, with healthcare adding around 11% and materials filling the rest. This mix gives IYK a bit more breadth than a pure staples play.
RSPS follows the S&P 500 Equal Weight Consumer Staples Index, assigning roughly equal weights of about 3% to each holding and rebalancing periodically. It contains 37 to 39 securities and charges a 0.40% expense ratio. Launched in 2006 by Invesco, the equal-weight approach keeps individual positions from dominating. Holdings typically include MNST (Monster Beverage), TGT (Target), BG (Bunge Global), ADM (Archer-Daniels-Midland), KO (Coca-Cola), WMT (Walmart), DLTR (Dollar Tree), KDP (Keurig Dr Pepper), PM (Philip Morris International), and CL (Colgate-Palmolive). The fund stays almost entirely in consumer staples, though it leans toward food processors, distributors, and discount retailers. This design lowers single-stock risk but reduces exposure to the biggest, most liquid names.
Both ETFs sit within the defensive consumer staples area, valued for steady earnings, pricing power, and reliable dividends. Recent cycles have challenged that stability through input-cost pressures, shifts toward value and private-label products, and softer volumes in packaged foods. Higher interest rates have also made these yield-oriented equities less appealing compared with bonds, while cyclical and tech areas drew more attention. Larger brand owners have generally held up better on margins than smaller, commodity-tied food and distribution companies, a distinction that separates the two portfolios.
Over recent periods, IYK has shown stronger relative momentum than RSPS, reflecting their different construction methods. IYK's cap-weighted focus on mega-cap leaders in household products, beverages, and tobacco has benefited from resilient pricing power. RSPS's equal-weight method gives more room to food distributors and grain processors that have dealt with margin pressure. The equal-weight tilt also points RSPS toward a lower average market cap, which can bring modestly higher volatility. While RSPS delivers a cleaner sector exposure, IYK's liquidity, scale, and slight cost edge have helped its positioning. I also checked this using Tickeron’s AI Screener to see how the two line up on momentum metrics.
Based on structural details and momentum trends, Tickeron's AI currently favors IYK over RSPS. IYK combines a marginally lower expense ratio, larger assets under management, and better trading liquidity, which supports tighter execution. Its market-cap exposure to the strongest franchises has delivered more consistent trends, while RSPS's tilt toward smaller staples names has weighed on relative results. RSPS provides a purer, less concentrated staples profile, yet IYK's mix of cost efficiency, liquidity, and healthcare diversification offers a more favorable risk-reward balance right now.
In my own analysis, I frequently rely on Tickeron's AI Screener to quickly compare ETFs and spot relative strength signals across sectors. The tool lets me apply filters for technical patterns, fundamentals, and performance metrics, helping surface ideas more efficiently than manual reviews. For staples exposure specifically, it highlights momentum differences in real time and supports more informed allocation decisions without adding unnecessary complexity to the process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows